|
|
• Education and Training Programs • HIPAA Last Modified: 11/07/03 |
Research on the GCRC
Publications |
JCR Impact Factor – 2001 Journal Citation Reports (Science Edition)
|
SPID |
*GCRC Cited |
# |
Publication Information (Journal Articles) |
JCR Impact Factor |
|
|
0035 |
Inpatient A |
1. |
Aarsland A, Wolfe RR. Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res 39:1280-1286, 1998. |
4.139 |
|
|
0103 |
Outpatient A |
2. |
Abdel-Rahman S, Salama AS, Au WW, Hamada FA. The role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes. Pharmacogenetics 10:239-249, 2000. |
4.371 |
|
|
0033 |
*Outpatient A |
3. |
Abdel-Rahman SZ, Ammenheuser MM, Ward JB Jr. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis 22:415-426, 2001. |
4.543 |
|
|
0033 |
*OutpatientA |
4. |
Abdel-Rahman SZ, El-Zein RA, Ammenheuser MM, Yang Z, Stock TH, Morandi M, Ward JB Jr. Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene. Environ Mol Mutagen 41:140-146, 2003. |
2.546 |
|
|
0009 |
Outpatient A |
5. |
Acosta PB, Yannicelli S, Singh R, Mofidi S, Steiner R, DeVincentis E, Jurecki E, Bernstein L, Gleason S, Chetty M, Rouse B. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J Am Diet Assoc 103;1167-1173, 2003. |
1.483 |
|
|
0027 |
*Outpatient A |
6. |
Alarcon GS, Friedman AW, Straaton KV, Moulds JM, Lisse J, Bastian HM, McGwin G, Bartolucci AA, Roseman JM, Reveille JD. Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus 8:197-209, 1999. |
1.875 |
|
|
0027 |
*Outpatient A |
7. |
Alarcon GS, McGwin G, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups, the lumina study: VII. Predictors of early mortality. Arthritis Rheum 45:191-202, 2001. |
7.389 |
|
|
0027 |
Outpatient A |
8. |
Alarcón GS, McGwin G, Jr, Bartolucci A, Roseman IM, Baethge B, Fessler B, Bastian HM, Friedman A W, Reveille JD for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups, the Lumina Study: IX. Differences in damage accrual. Arthritis Rheum 44:2797-2806, 2001. |
7.389 |
|
|
0027 |
Outpatient A |
9. |
Alarcón GS, Rodríguez JL, Benavides G, Jr, Brooks K, Kurusz H, Reveille JD. Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health-related attitudes and behaviors and disease activity in Hispanic patients from the LUMINA cohort. Arthritis Care Res 12:267-274, 1999. |
1.068 |
|
|
0027 |
Outpatient A |
10. |
Alarcón GS, Roseman J, Bartolucci AA, Friedman AW, Moulds JM, Goel N, Straaton KV, Reveille JD. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum 41:1173-1180, 1998. |
7.389 |
|
|
0259 |
*Outpatient A |
11. |
Aljubeh JM, Miller AL, Meyer III WJ, Thompson, EB. Glucocorticoid receptor characteristics in normal children Æs leukocytes: Correlation with gender, weight, age and plasma. Cortisol J Pedi Endo 14 :1641-1647, 2001. |
Not Available |
|
|
0071 |
Outpatient A |
12. |
Alshanti M, Eledrisi MS, Jones E. Rhabdomyolysis associated with hyperthyroidism. Am J Emer Med 19:317, 2001. |
1.133 |
|
|
0080 |
*Outpatient A |
13. |
Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT. Fanconi anemia: Myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 117:125-131, 2000. |
1.529 |
|
|
0033 |
Outpatient A |
14. |
Ammenheuser MM, Bechtold WE, Abdel-Rahman SZ, Rosenblatt JI, Hastings-Smith DA, Ward JB Jr. Assessment of 1,3-butadiene exposure in polymer production workers using hprt mutation in lymphocytes as a biomarker. Environ Health Persp 109:1249-1255, 2001. |
3.137 |
|
|
0103 |
Outpatient A |
15. |
Au WW, Sierra-Torres HC, Cajas-Salazar N, Salama AS. Inheritance of polymorphic metabolizing genes on environmental disease and on quality of life. Mutat Res 428:131-140, 1999. |
2.545 |
|
|
0103 |
Outpatient A |
16. |
Au WW, Anwar W, Sram RJ, Chulasiri M, Ribeiro L. International conferences on environmental mutagens in human populations – opportunities, accomplishments and challenges. Monographs published in Mutat Res 428:1-376, 1999. |
2.545 |
|
|
0103 |
Outpatient A |
17. |
Au WW, Badary OA, Heo MY. Cytogenetic assays for monitoring populations exposed to environmental mutagens. Occ Med 16:345-57, 2001. |
1.973 |
|
|
0103 |
Outpatient A |
18. |
Au WW, Oberheitmann B, Heo MY, Hoffmann W, Oh HY. Biomarker monitoring for health risk based on sensitivity to environmental mutagens. Rev on Environ Health 16:41-64, 2001. |
Not Available |
|
|
0103 |
Outpatient A |
19. |
Au WW, Oh HY, Grady J, Salama S, Heo MY. Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environ Mol Mutag 37 :215-225, 2001. |
2.276 |
|
|
0103 |
* |
20. |
Au WW, Oh HY, Salama S, Kietthubthew S. Genetic susceptibility to environmental disease. Life Sciences 313:312-318, 2000. |
1.758 |
|
|
0103 |
Outpatient A |
21. |
Au WW, Sierra-Torres H, Cajas-Salazar N, Shipp BK, Legator MS. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Persp 107:501-505, 1999. |
3.137 |
|
|
0103 |
Outpatient A |
22. |
Au WW. Susceptibility of children to environmental toxic substances. Int J Hyg Environ Health 205:501-503, 2002. |
0.480 |
|
|
0103 |
Outpatient A |
23. |
Au WW. Lifestyle factors and acquired susceptibility to environmental disease. Int J Hygiene and Env Health 204:17 – 22, 2001. |
0.480 |
|
|
0103 |
*Outpatient A |
24. |
Au WW, Salama SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Persp 111:1843-1850, 2003. |
3.452 |
|
|
0072 |
Inpatient A |
25. |
Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty Jr CL, Urban RJ. Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 280:E383-E390, 2001. |
3.324 |
|
|
0069 |
*Outpatient A |
26. |
Baima J, Nicolaou M, Schwartz F, DeStefano AL, Manolis A, Garvas I, Laffer CL, Elijovick F, Farrer L, Baldwin CT, Gavras H. Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. Hypertension 34:4-7, 1999. |
5.364 |
|
|
0320 |
Outpatient A |
27. |
Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd MW. Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 181: 498-504, 2001. |
4.910 |
|
|
0018 0307 |
Inpatient A |
28. |
Barone GW, Gurley BJ, Anderson KE, Ketel BL, Abul-Ezz SR. The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria. J Clin Pharmacol 41:113-115, 2001. |
2.167 |
|
|
0096 0343 |
Inpatient A |
29. |
Barret JP, Dziewulski P, Wolf SE, Desai MH, Herndon DN. Effects of recombinant human growth hormone on burn scar development. Plast Reconstr Surg 104:726-729, 1999. |
1.436 |
|
|
0027 |
Outpatient A |
30. |
Bastian HM, Roseman JM, McGwin G, Jr, Alarcón GS, Friedman AW, Fessler BJ, Baethge BA, Reveille JD for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups XII: Risk factors for lupus nephritis after diagnosis. Lupus 11:152-160, 2002. |
1.875 |
|
|
0016 |
*Outpatient A |
31. |
Berenson AB, Chacko MR, Wiemann CM, et al. Use of hymenal measurements in the diagnosis of previous penetration. Pediatrics 109:228-235, 2002. |
3.708 |
|
|
0016 |
*Outpatient A |
32. |
Berenson AB, Chacko MR, Wiemann CM, Mishaw CO, Friedrich WN, Grady JJ. A case-control study of anatomic changes resulting from sexual abuse. Am J Obstet Gynecol 182:820-831, 2000. |
2.871 |
|
|
0016 |
*Outpatient A |
33. |
Berenson AB, Grady JJ. A longitudinal study of hymenal development from 3 to 9 years of age. J Pediatr 140:600-607, 2002. |
3.536 |
|
|
0302 |
Outpatient A |
34. |
Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 98:576-582, 2001. |
2.196 |
|
|
0011 |
Inpatient A |
35. |
Biolo G, Williams BD, Fleming RY, Wolfe RR. Insulin action on muscle protein kinetics and amino acid transport during recovery after resistance exercise. Diabetes 48:949-957, 1999. |
7.700 |
|
|
0011 |
*Inpatient A |
36. |
Bohe J, Low A, Wolfe RR, Rennie MJ. Latency and duration of stimulation of human muscle protein synthesis during continuous infusion of amino acids. J Physiol 532:575-579, 2001. |
4.476 |
|
|
0011 |
*Inpatient A |
37. |
Bohe J, Low A, Wolfe RR, Rennie MJ. Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physio 552:315-24, 2003. |
4.650 |
|
|
0103 |
Outpatient A |
38. |
Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 511:73-86, 2002. |
2.545 |
|
|
0258 |
Inpatient A |
39. |
Borsheim E, Tipton KD, Wolf SE, Wolfe RR. Essential amino acids and muscle protein recovery from resistance exercise. Am J Physiol: Endocrinol Metabol 283:E648-E657, 2002. |
3.324 |
|
|
0345 |
*Inpatient A Outpatient A |
40. |
Børsheim E, Cree M, Tipton KD, Elliot TA, Aarsland A, Wolfe RR. Effect of carbohydrate intake on net muscle protein synthesis during recovery from resistance exercise. J Appl Physiol Accepted 08/01/2003, 2004. |
2.720 |
|
|
0287 |
|||||